VistaGen Therapeutics (VTGN) P/E (2016 - 2026)
VistaGen Therapeutics (VTGN) P/E from May 6, 2016 to Jul 21, 2026. The TTM VistaGen Therapeutics (VTGN) P/E is -0.55. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of VistaGen Therapeutics (VTGN)
| Year | P/E | Change |
|---|---|---|
| 2026 | -0.55 | -62.82% |
| 2025 | -1.48 | -77.00% |
| 2024 | -6.43 | -17.91% |
| 2023 | -7.83 | +542.76% |
| 2022 | -1.22 | -96.62% |
| 2021 | -36.07 | +136.75% |
| 2020 | -15.24 | +181.16% |
| 2019 | -5.42 | +4.05% |
| 2018 | -5.21 | -80.95% |
| 2017 | -27.35 | -70.24% |
| 2016 | -91.90 | N/A |
Comparison VistaGen Therapeutics (VTGN) P/E with competitors
VistaGen Therapeutics (VTGN) P/E is -0.55.